Page 126 - Annual report 2021-22

Annual Report 2021-22 |

Dasgupta U, Patil VS, Bajaj A. ACS APPLIED MATERIALS & INTERFACES;2021 SEP
22;37;13;44041-44053 [Journal Article]
10.38
140. The deleterious impact of a non-synonymous SNP on protein structure and function
is apparent in hypertension. Sharma K, Hema K, Bhatraju NK, Kukreti R, Das RS, Gupta MD,
Syed MA, Pasha MAQ. JOURNAL OF MOLECULAR MODELING;2021 DEC 27;1;28;14 [Journal 109
Article]
1.81
141. Genetic epidemiology of autoinflammatory disease variants in Indian population from
1029 whole genomes. Jain A, Bhoyar RC, Pandhare K, Mishra A*, Sharma D, Imran M,
Senthivel V, Divakar MK, Rophina M, Jolly B, Batra A, Sharma S, Siwach S, Jadhao AG, Palande
NV, Jha GN, Ashrafi N, Mishra PK*, A K V, Jain S, Dash D, Kumar NS, Vanlallawma A, Sarma RJ,
Chhakchhuak L, Kalyanaraman S, Mahadevan R, Kandasamy S, B M P, Rajagopal RE, Ramya J
E, Devi P N, Bajaj A, Gupta V, Mathew S, Goswami S, Mangla M, Prakash S, Joshi K, Meyakumla,
S S, Gajjar D, Soraisham R, Yadav R, Devi YS, Gupta A, Mukerji M, Ramalingam S, B K B, Scaria
V, Sivasubbu S. JOURNAL, GENETIC ENGINEERING & BIOTECHNOLOGY;2021 DEC 14;1;19;183
[Journal Article]
3.8
142. Targeted silencing of Interleukin 1 receptor type I (IL1R1) using dead Cas9 (dCas9)
conjugated telomeric repeat binding factor 2 (TRF2) and its therapeutic potential. Subhajit
Dutta, Ananda Kishore Mukherjee, Antara Sengupta, Shuvra Shekhar Roy. 0015NF2022
[PATENT]

143. Alternative splicing modulation mediated by G-quadruplex structures in MALAT1
lncRNA. Ghosh A, Pandey SP, Ansari AH, Sundar JS, Singh P, Khan Y, Ekka MK, Chakraborty D,
Maiti S. NUCLEIC ACIDS RESEARCH;2022 JAN 11;1;50;378-396 [Journal Article]
16.971
144. Lyz2-Cre-Mediated Genetic Deletion of Septin7 Reveals a Role of Septins in
Macrophage Cytokinesis and Kras-Driven Tumorigenesis. Menon MB, Yakovleva T, Ronkina N,
Suwandi A, Odak I, Dhamija S, Sandrock I, Hansmann F, Baumgärtner W, Förster R, Kotlyarov
A, Gaestel M. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY;2021;9;795798 [Journal
Article]
6.684
145. A phase 2 single center open label randomised control trial for convalescent plasma
therapy in patients with severe COVID-19. Ray Y, Paul SR, Bandopadhyay P, D'Rozario R, Sarif
J, Raychaudhuri D, Bhowmik D, Lahiri A, Vasudevan JS, Maurya R, Kanakan A, Sharma S, Kumar
M, Singh P, Roy R, Chaudhury K, Maiti R, Bagchi S, Maiti A, Perwez MM, Mondal A, Tewari A,
Mandal S, Roy A, Saha M, Biswas D, Maiti C, Bhaduri R, Chakraborty S, Sarkar BS, Haldar A,
Saha B, Sengupta S, Pandey R, Chatterjee S, Bhattacharya P, Paul S, Ganguly D. NATURE
COMMUNICATIONS;2022 JAN 19;1;13;383 [Randomized Controlled Trial]
14.92
146. Adaptive capacity to dietary Vitamin B12 levels is maintained by a gene-diet
interaction that ensures optimal life span. Nair T, Chakraborty R, Singh P, Rahman SS, Bhaskar
AK, Sengupta S, Mukhopadhyay A. AGING CELL;2022 JAN;1;21;E13518 [Journal Article]